SCHEMBL29950440

SCHEMBL29950440

CCCCOC(=O)N1CCc2ccc(O)cc2C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 5/20 0.55
▸ ESR1 P03372 5/20 0.52
▸ TMEM97 Q5BJF2 8/20 0.49
▸ SIGMAR1 Q99720 8/20 0.49
▸ NR1H2 P55055 2/20 0.45
▸ HRH3 Q9Y5N1 2/20 0.45
▸ LMNA P02545 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ HRH2 P25021 2/20 0.43
▸ HTR2C P28335 2/20 0.43
▸ HTR1E P28566 2/20 0.43
▸ HRH1 P35367 2/20 0.43
▸ HTR1A P08908 1/20 0.43
▸ CHRM5 P08912 1/20 0.43
▸ SLC6A2 P23975 1/20 0.43
▸ ADRA1D P25100 1/20 0.43
▸ HTR1B P28222 1/20 0.43
▸ HTR2A P28223 1/20 0.43
▸ HTR2B P41595 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21465756 1.00 ESR2 (0.55) ESR2ESR1TMEM97SIGMAR1NR1H2
SCHEMBL3874751 0.88 ESR2 (0.61) ESR2ESR1TMEM97SIGMAR1NR1H2
SCHEMBL38664500 0.86 ABHD6 (0.56) TMEM97SIGMAR1NR1H2HRH3LMNA
SCHEMBL8440118 0.86 NR1H2 (0.62) TMEM97SIGMAR1NR1H2HRH3LMNA
SCHEMBL30097032 0.84 TMEM97 (0.45) ESR2TMEM97SIGMAR1NR1H2HRH3
SCHEMBL30647004 0.84 PRMT5 (0.55) SMN1; SMN2TSHR
SCHEMBL15355387 0.84 PRMT5 (0.55) SMN1; SMN2TSHR
SCHEMBL38662736 0.83 SGPL1 (0.47) TMEM97SIGMAR1NR1H2HRH3HRH2
SCHEMBL30130837 0.83 DPP7 (0.48) TMEM97SIGMAR1LMNASMN1; SMN2HRH2
SCHEMBL8264660 0.81 ABHD6 (0.56) ESR2ESR1TMEM97SIGMAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4337207-A1 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR Opna Bio SA (CH) 2024-03-20 — — EP disclosed
WO-2022240966-A1 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR OPNA IMMUNO-ONCOLOGY SA (CH) 2022-11-17 — — WO disclosed
Send feedback